tanshinone ii a has been researched along with ag 538 in 1 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (ag 538) | Trials (ag 538) | Recent Studies (post-2010) (ag 538) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 30 | 0 | 15 |
| Protein | Taxonomy | tanshinone ii a (IC50) | ag 538 (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 4.0628 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 4.0628 | |
| alkaline phosphatase, intestinal | Homo sapiens (human) | 3.545 | |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | 9.49 | |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 3.6945 | |
| alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | 5.59 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.3603 | |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | 0.061 | |
| DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | 0.28 | |
| large T antigen | Betapolyomavirus macacae | 0.82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laev, SS; Lavrik, OI; Salakhutdinov, NF | 1 |
1 review(s) available for tanshinone ii a and ag 538
| Article | Year |
|---|---|
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Inhibitors; Humans; Neoplasms; Oxidation-Reduction | 2017 |